Surgonomics: Health Care Financing Policy for Hospitalized Otolaryngology Patients

Eric Muñoz, Gerald Zahtz, Jonathan Goldstein, Teresa Benacquista, Katherine Mulloy, Leslie Wise

Research output: Contribution to journalArticle

Abstract

• The Medicare diagnosis related group (DRG) prospective payment model is changing hospital payment. Currently many states are using DRG prospective "All Payor Systems" for hospital reimbursement. In All Payor Systems, Medicare, Medicaid, Blue Cross, and other commercial insurers pay by the DRG mode; New York State has been All Payor since Jan 1, 1988. This study simulated DRG All Payor methods on a large sample (N=1074) of adult otolaryngology patients for a two-year period using both federal and New York DRG reimbursement now in effect. Both Medicare and Medicaid patients had (on average) a longer hospital stay and total hospital cost compared with patients from Blue Cross and other commercial payors. Medicare and Medicaid patients also had a greater severity of illness compared with patients from Blue Cross or other payors. All payors (ie, Medicaid, Blue Cross, and commercial insurers), except Medicare, generated financial risk under the DRG All Payor scheme. These data suggest that state and private payors may be underreimbursing for the care of the hospitalized otolaryngology patient using the DRG prospective hospital payment scheme. Health care financing policy described in this study may limit both the access and/or the quality of care for many otolaryngology patients in the future. (Arch Otolaryngol Head Neck Surg 1988;114:1317-1320)

Original languageEnglish (US)
Pages (from-to)1317-1320
Number of pages4
JournalArchives of Otolaryngology - Head and Neck Surgery
Volume114
Issue number11
DOIs
StatePublished - 1988

Fingerprint

Healthcare Financing
Diagnosis-Related Groups
Otolaryngology
Blue Cross Blue Shield Insurance Plans
Medicare
Delivery of Health Care
Medicaid
Insurance Carriers
Hospital Costs
Quality of Health Care
Length of Stay
Head

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery

Cite this

Surgonomics : Health Care Financing Policy for Hospitalized Otolaryngology Patients. / Muñoz, Eric; Zahtz, Gerald; Goldstein, Jonathan; Benacquista, Teresa; Mulloy, Katherine; Wise, Leslie.

In: Archives of Otolaryngology - Head and Neck Surgery, Vol. 114, No. 11, 1988, p. 1317-1320.

Research output: Contribution to journalArticle

Muñoz, Eric ; Zahtz, Gerald ; Goldstein, Jonathan ; Benacquista, Teresa ; Mulloy, Katherine ; Wise, Leslie. / Surgonomics : Health Care Financing Policy for Hospitalized Otolaryngology Patients. In: Archives of Otolaryngology - Head and Neck Surgery. 1988 ; Vol. 114, No. 11. pp. 1317-1320.
@article{24204b09a3a6423486f35482367f0fc6,
title = "Surgonomics: Health Care Financing Policy for Hospitalized Otolaryngology Patients",
abstract = "• The Medicare diagnosis related group (DRG) prospective payment model is changing hospital payment. Currently many states are using DRG prospective {"}All Payor Systems{"} for hospital reimbursement. In All Payor Systems, Medicare, Medicaid, Blue Cross, and other commercial insurers pay by the DRG mode; New York State has been All Payor since Jan 1, 1988. This study simulated DRG All Payor methods on a large sample (N=1074) of adult otolaryngology patients for a two-year period using both federal and New York DRG reimbursement now in effect. Both Medicare and Medicaid patients had (on average) a longer hospital stay and total hospital cost compared with patients from Blue Cross and other commercial payors. Medicare and Medicaid patients also had a greater severity of illness compared with patients from Blue Cross or other payors. All payors (ie, Medicaid, Blue Cross, and commercial insurers), except Medicare, generated financial risk under the DRG All Payor scheme. These data suggest that state and private payors may be underreimbursing for the care of the hospitalized otolaryngology patient using the DRG prospective hospital payment scheme. Health care financing policy described in this study may limit both the access and/or the quality of care for many otolaryngology patients in the future. (Arch Otolaryngol Head Neck Surg 1988;114:1317-1320)",
author = "Eric Mu{\~n}oz and Gerald Zahtz and Jonathan Goldstein and Teresa Benacquista and Katherine Mulloy and Leslie Wise",
year = "1988",
doi = "10.1001/archotol.1988.01860230111037",
language = "English (US)",
volume = "114",
pages = "1317--1320",
journal = "Archives of Otolaryngology",
issn = "2168-6181",
publisher = "American Medical Association",
number = "11",

}

TY - JOUR

T1 - Surgonomics

T2 - Health Care Financing Policy for Hospitalized Otolaryngology Patients

AU - Muñoz, Eric

AU - Zahtz, Gerald

AU - Goldstein, Jonathan

AU - Benacquista, Teresa

AU - Mulloy, Katherine

AU - Wise, Leslie

PY - 1988

Y1 - 1988

N2 - • The Medicare diagnosis related group (DRG) prospective payment model is changing hospital payment. Currently many states are using DRG prospective "All Payor Systems" for hospital reimbursement. In All Payor Systems, Medicare, Medicaid, Blue Cross, and other commercial insurers pay by the DRG mode; New York State has been All Payor since Jan 1, 1988. This study simulated DRG All Payor methods on a large sample (N=1074) of adult otolaryngology patients for a two-year period using both federal and New York DRG reimbursement now in effect. Both Medicare and Medicaid patients had (on average) a longer hospital stay and total hospital cost compared with patients from Blue Cross and other commercial payors. Medicare and Medicaid patients also had a greater severity of illness compared with patients from Blue Cross or other payors. All payors (ie, Medicaid, Blue Cross, and commercial insurers), except Medicare, generated financial risk under the DRG All Payor scheme. These data suggest that state and private payors may be underreimbursing for the care of the hospitalized otolaryngology patient using the DRG prospective hospital payment scheme. Health care financing policy described in this study may limit both the access and/or the quality of care for many otolaryngology patients in the future. (Arch Otolaryngol Head Neck Surg 1988;114:1317-1320)

AB - • The Medicare diagnosis related group (DRG) prospective payment model is changing hospital payment. Currently many states are using DRG prospective "All Payor Systems" for hospital reimbursement. In All Payor Systems, Medicare, Medicaid, Blue Cross, and other commercial insurers pay by the DRG mode; New York State has been All Payor since Jan 1, 1988. This study simulated DRG All Payor methods on a large sample (N=1074) of adult otolaryngology patients for a two-year period using both federal and New York DRG reimbursement now in effect. Both Medicare and Medicaid patients had (on average) a longer hospital stay and total hospital cost compared with patients from Blue Cross and other commercial payors. Medicare and Medicaid patients also had a greater severity of illness compared with patients from Blue Cross or other payors. All payors (ie, Medicaid, Blue Cross, and commercial insurers), except Medicare, generated financial risk under the DRG All Payor scheme. These data suggest that state and private payors may be underreimbursing for the care of the hospitalized otolaryngology patient using the DRG prospective hospital payment scheme. Health care financing policy described in this study may limit both the access and/or the quality of care for many otolaryngology patients in the future. (Arch Otolaryngol Head Neck Surg 1988;114:1317-1320)

UR - http://www.scopus.com/inward/record.url?scp=0023734461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023734461&partnerID=8YFLogxK

U2 - 10.1001/archotol.1988.01860230111037

DO - 10.1001/archotol.1988.01860230111037

M3 - Article

C2 - 3139014

AN - SCOPUS:0023734461

VL - 114

SP - 1317

EP - 1320

JO - Archives of Otolaryngology

JF - Archives of Otolaryngology

SN - 2168-6181

IS - 11

ER -